What does a Wegovy pen cost in the UK?

What the evidence says Wegovy costs to run, and why pricing varies

NICE's appraisal of semaglutide for weight management (TA875) confirmed its clinical case: in the STEP 1 trial, participants lost an average of around 15% of body weight over 68 weeks. That result sits behind a medicine that, at licensed maintenance doses, requires monthly supply. Most private providers set pricing by dose, meaning you typically pay more per month as you titrate upward, 0.25mg starter pens cost less than the 2.4mg maintenance dose, and the recently approved 7.2mg single-dose pen, cleared by the MHRA in April 2026, sits at the top of the range.

Prices across the private market have broadly settled at roughly £149 to £375 per four-week supply, hedged because individual providers set their own rates and these figures move. The Eli Lilly list-price increase of September 2025 (widely reported at the time) reset the floor for many services. One useful check: any published monthly price should reflect the specific dose you are on, not just the entry dose, which can lead to an unpleasant surprise mid-treatment, and understanding how much semaglutide each pen actually contains helps you compare doses accurately across different products.

Semaglutide is not orlistat, bought over a pharmacy counter. It requires a full clinical assessment every time. Understanding what shapes the total cost of Wegovy treatment is a better frame than comparing a single month's pen price.

What headline Wegovy prices often leave out

A number that a lot of people trip over: a bare pen price is not the same as a treatment price. Some services charge separately for the initial consultation, for the written prescription, for delivery, and for any clinical support after the pen arrives. Add those up across a treatment course and the gap between the cheapest-looking listing and the real total cost narrows considerably.

Clinical aftercare matters here in a way it wouldn't for, say, a vitamin supplement. Semaglutide is titrated over months, your prescriber should be reviewing whether your dose is right and how you're tolerating each step, and side effects (mostly gastrointestinal, particularly in the early weeks) occasionally need clinical input. A service that doesn't price in that support either doesn't provide it, or charges for it separately when you need it most.

Delivery is another line. Free tracked next-working-day delivery sounds like a small thing, but temperature-controlled dispatch for a refrigerated medicine is not the same as posting a book. More detail on what a Wegovy pen price should realistically cover is worth reading before you choose a provider.

Where nume sits on price, and why that's deliberate

We are not the cheapest option for Wegovy, and we don't try to be. One transparent price covers your free consultation, prescription, treatment, free next-working-day DPD delivery and seven-day aftercare. There is no subscription, no auto-renewal, and no moment when a hidden fee appears. Every repeat order is assessed by a real clinician before dispatch, a named GPhC-registered prescriber reads your notes, not software.

That clinical model costs more to run than a bare-fulfilment operation. We think, for a prescription medicine taken weekly for months, that's the right trade-off. Current treatment pricing is on our treatment page; we don't publish per-pen prices in editorial because they shift, and what you pay in month four may differ from month one as your dose increases. A prescriber explains that before you commit, there are no surprises.

The common misconception worth gently setting aside: that a lower price signals better value. For a medicine that only works with proper titration, genuine supply-chain oversight and clinical follow-up, the cheapest listing often answers the wrong question entirely. Explore the full cost picture for Wegovy if you want the broader breakdown.

The supply chain question every buyer should ask

The MHRA has issued repeated warnings about counterfeit weight-loss pens sold online, some containing insulin instead of semaglutide, others simply saline. The enforcement picture in 2025 included approximately 20 million doses of illegally traded weight-loss medicines (around £45 million street value) seized, and a counterfeit tirzepatide manufacturing site raided. The MHRA's Yellow Card scheme accepts reports of suspect sellers as well as side effects.

The practical check is straightforward: any online pharmacy dispensing a prescription medicine in the UK must be registered with the GPhC. You can verify a pharmacy's registration number directly on the GPhC register. If a seller is offering Wegovy at prices far below market, without requiring a clinical consultation, or via social media without a regulated pharmacy behind them, those are red flags that the medicine's provenance cannot be guaranteed.

Saving a modest sum on a single pen is not a good trade against receiving a counterfeit product. Price is the wrong test for a prescription medicine. Safety infrastructure (a registered pharmacy, a qualified prescriber, an authorised supply chain) is the right one. If you want to understand your eligibility for treatment, start with a free consultation and let a prescriber work through it with you.